InMed Pharmaceuticals – Introducing the BayMedica Team

InMed Pharmaceuticals – Introducing the BayMedica Team

InMed Pharmaceuticals — 14 videos in collection

More on this equity

InMed Pharmaceuticals is a global leader in the manufacture and development of rare cannabinoids. Together with its recently acquired subsidiary, BayMedica, it has unparalleled cannabinoid manufacturing capabilities to serve a wide spectrum of consumer markets, including pharmaceutical and health and wellness.

In this video series, we’ll be introducing the BayMedica team, discussing the team members’ impressive careers and experience in the industry and what excites them about the InMed/BayMedica acquisition. Today’s video highlights Charles Marlowe, VP of Chemistry.


You may also be interested in these:

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free